Charles E. Glatt

9.8k total citations · 3 hit papers
52 papers, 7.9k citations indexed

About

Charles E. Glatt is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Charles E. Glatt has authored 52 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cellular and Molecular Neuroscience, 19 papers in Molecular Biology and 15 papers in Cognitive Neuroscience. Recurrent topics in Charles E. Glatt's work include Stress Responses and Cortisol (12 papers), Neuroscience and Neuropharmacology Research (10 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Charles E. Glatt is often cited by papers focused on Stress Responses and Cortisol (12 papers), Neuroscience and Neuropharmacology Research (10 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Charles E. Glatt collaborates with scholars based in United States, Qatar and Canada. Charles E. Glatt's co-authors include Solomon H. Snyder, Paul M. Hwang, David S. Bredt, Charles J. Lowenstein, David J. Hirsch, Ajay Verma, Gabriele V. Ronnett, Majid Fotuhi, Solomon H. Snyder and David S. Bredt and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Charles E. Glatt

51 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase

1991 2.0k citations David S. Bredt, Paul M. Hwang et al. Nature profile →
Carbon Monoxide: a Putative Neural Messenger

1993 1.3k citations Charles E. Glatt, Solomon H. Snyder et al. Science profile →
Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase

1991 1.2k citations David S. Bredt, Charles E. Glatt et al. Neuron profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles E. Glatt United States	30	2.9k	2.6k	2.5k	1.1k	969	52	7.9k
David F. Wozniak United States	65	4.6k 1.6×	4.4k 1.7×	4.2k 1.7×	910 0.8×	1.2k 1.2×	139	15.0k
D.J. Reis United States	52	2.8k 1.0×	1.6k 0.6×	3.9k 1.6×	2.2k 2.0×	924 1.0×	132	8.0k
Hans‐Gert Bernstein Germany	51	3.1k 1.1×	1.8k 0.7×	2.9k 1.2×	560 0.5×	1.3k 1.3×	254	10.3k
Solomon H. Snyder United States	20	3.3k 1.2×	3.2k 1.2×	3.3k 1.4×	1.3k 1.2×	318 0.3×	22	8.4k
Paul G.M. Luiten Netherlands	56	2.8k 1.0×	2.5k 1.0×	3.7k 1.5×	1.4k 1.3×	2.0k 2.0×	202	11.3k
Lars Oreland Sweden	61	3.1k 1.1×	1.8k 0.7×	5.1k 2.1×	514 0.5×	1.5k 1.5×	346	13.5k
Boris Tabakoff United States	61	4.7k 1.6×	1.8k 0.7×	6.4k 2.6×	504 0.5×	1.2k 1.3×	321	12.1k
Jacques Epelbaum France	64	4.0k 1.4×	3.0k 1.1×	4.1k 1.7×	3.7k 3.4×	975 1.0×	307	13.1k
J Axelrod United States	58	4.7k 1.6×	2.0k 0.8×	4.5k 1.8×	1.3k 1.2×	624 0.6×	146	11.5k
Kazuhiko Yanai Japan	56	3.1k 1.1×	3.6k 1.4×	2.1k 0.8×	1.2k 1.1×	1.6k 1.7×	369	11.3k

Countries citing papers authored by Charles E. Glatt

Since Specialization

Citations

This map shows the geographic impact of Charles E. Glatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Glatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Glatt more than expected).

Fields of papers citing papers by Charles E. Glatt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Glatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Glatt. The network helps show where Charles E. Glatt may publish in the future.

Co-authorship network of co-authors of Charles E. Glatt

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Glatt. A scholar is included among the top collaborators of Charles E. Glatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Glatt. Charles E. Glatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Heleniak, Charlotte, Bonnie Goff, Laurel J. Gabard‐Durnam, et al.. (2023). Telomere Erosion and Depressive Symptoms Across Development Following Institutional Care. Journal of the American Academy of Child & Adolescent Psychiatry. 63(3). 365–375. 6 indexed citations

Rothbaum, Barbara O., JoAnn Difede, Albert Rizzo, et al.. (2023). Virtual Reality Exposure Therapy Compared to Prolonged Exposure Therapy With and Without D-Cycloserine. Biological Psychiatry. 93(9). S28–S29.

Difede, JoAnn, Barbara O. Rothbaum, Albert Rizzo, et al.. (2022). Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer. Translational Psychiatry. 12(1). 299–299. 31 indexed citations

Difede, JoAnn, Barbara O. Rothbaum, Albert Rizzo, et al.. (2019). Enhanced exposure therapy for combat-related Posttraumatic Stress Disorder (PTSD): Study protocol for a randomized controlled trial. Contemporary Clinical Trials. 87. 105857–105857. 9 indexed citations

Subaran, Ryan, et al.. (2016). Novel variants in ZNF34 and other brain‐expressed transcription factors are shared among early‐onset MDD relatives. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 171(3). 333–341. 21 indexed citations

Yoon, Yonejung, Minseok Song, Tal Nuriel, et al.. (2013). Anxiety-associated alternative polyadenylation of the serotonin transporter mRNA confers translational regulation by hnRNPK. Proceedings of the National Academy of Sciences. 110(28). 11624–11629. 35 indexed citations

Kanellopoulos, Dora, Faith M. Gunning, Sarah Shizuko Morimoto, et al.. (2010). Hippocampal Volumes and the Brain-Derived Neurotrophic Factor val66met Polymorphism in Geriatric Major Depression. American Journal of Geriatric Psychiatry. 19(1). 13–22. 49 indexed citations

Alexopoulos, George S., Charles E. Glatt, Matthew J. Hoptman, et al.. (2010). BDNF Val66met polymorphism, white matter abnormalities and remission of geriatric depression. Journal of Affective Disorders. 125(1-3). 262–268. 64 indexed citations

SOLIMAN, F. S. G., Charles E. Glatt, Kevin G. Bath, et al.. (2010). A Genetic Variant BDNF Polymorphism Alters Extinction Learning in Both Mouse and Human. Science. 327(5967). 863–866. 463 indexed citations

10.

Alexopoulos, George S., Christopher F. Murphy, Faith M. Gunning‐Dixon, et al.. (2009). Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression. Journal of Affective Disorders. 119(1-3). 132–141. 72 indexed citations

11.

Casey, B.J., Charles E. Glatt, Nim Tottenham, et al.. (2009). Brain-derived neurotrophic factor as a model system for examining gene by environment interactions across development. Neuroscience. 164(1). 108–120. 111 indexed citations

12.

Wahner, Angelika D., Charles E. Glatt, Jeff M. Bronstein, & Beate Ritz. (2006). Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinsonâs disease.. Europe PMC (PubMed Central). 40 indexed citations

13.

Glatt, Charles E., Angelika D. Wahner, Daniel J. White, Andrés Ruiz‐Linares, & Beate Ritz. (2005). Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women. Human Molecular Genetics. 15(2). 299–305. 81 indexed citations

14.

Burman, Jonathon L., Cindy Tran, Charles E. Glatt, Nelson B. Freimer, & Robert H. Edwards. (2004). The effect of rare human sequence variants on the function of vesicular monoamine transporter 2. Pharmacogenetics. 14(9). 587–594. 13 indexed citations

15.

Glatt, Charles E., et al.. (2003). Re‐Screening serotonin receptors for genetic variants identifies population and molecular genetic complexity. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 124B(1). 92–100. 12 indexed citations

16.

Glatt, Charles E. & Nelson B. Freimer. (2002). Association analysis of candidate genes for neuropsychiatric disease: the perpetual campaign. Trends in Genetics. 18(6). 307–312. 42 indexed citations

17.

Steiner, Joseph, Ted M. Dawson, Majid Fotuhi, et al.. (1992). High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature. 358(6387). 584–587. 292 indexed citations

18.

Hwang, Paul M., Charles E. Glatt, David S. Bredt, Gary Yellen, & Solomon H. Snyder. (1992). A novel K+ channel with unique localizations in mammalian brain: Molecular cloning and characterization. Neuron. 8(3). 473–481. 118 indexed citations

19.

Bredt, David S., Charles E. Glatt, Paul M. Hwang, et al.. (1991). Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron. 7(4). 615–624. 1241 indexed citations breakdown →

20.

Bredt, David S., et al.. (1991). Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 351(6329). 714–718. 2005 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact